GT Biopharma (GTBP) Net Margin (2010 - 2015)

GT Biopharma (GTBP) has reported Net Margin for 5 consecutive years, with 134300.0% the latest figure, recorded in Q2 2015.

• On a quarterly basis, Net Margin changed N/A year-over-year to 134300.0% in Q2 2015; TTM through Mar 2016 was 68695.0%, a 8259627.0% increase from a year earlier, with the FY2015 full-year figure at 79485.19%, down 4095240.0% from the prior year.
• Net Margin was 134300.0% for Q2 2015 at GT Biopharma, up from 293085.71% in the prior quarter.
• Over five years, Net Margin peaked at 134300.0% in Q2 2015 and troughed at 293085.71% in Q1 2015.
• A 4-year average of 52244.66% and a median of 9615.0% in 2011 frame the typical range for Net Margin.
• Across the five-year window, Net Margin tumbled 17460000 bps in 2012 and surged 6204773 bps in 2013, its largest moves.
• Over 4 years, Net Margin stood at 37933.33% in 2011, then jumped by 99 bps to 375.8% in 2012, then soared by 246 bps to 547.73% in 2013, then jumped by 24420 bps to 134300.0% in 2015.
• The last three Net Margin figures came in at 134300.0% (Q2 2015), 293085.71% (Q1 2015), and 547.73% (Q1 2013), per Business Quant data.